ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Pharsight Corp (MM)

Pharsight Corp (MM) (PHST)

5.48
0.00
(0.00%)
Cerrado 11 Diciembre 3:00PM
5.48
0.00
( 0.00% )
Pre Mercado: 6:00PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
5.48
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
5.48
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

PHST Últimas noticias

Pharsight Launches PK Accelerator(TM)

PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading...

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo Correlation Modeling in Drug Development MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Pharsight(R) Corporation...

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Dr. Farkad Ezzet Will Present on the Strategic Value of Literature Modeling to Assess Disease Progression and Drug Attributes in Clinical Development MOUNTAIN VIEW, Calif., June 17...

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Dr. Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents MOUNTAIN VIEW, Calif., June 12...

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified Programming Approaches of Population Model User Interfaces MOUNTAIN VIEW...

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Dr. Helen Kastrissios Will Present on Communicating the Value of Pharmacodynamic Modeling in Clinical Drug Development MOUNTAIN VIEW, Calif., May 27 /PRNewswire-FirstCall/ -- Pharsight...

Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic...

Pharsight Achieves $7.6 Million In Quarterly Revenue

Fourth Quarter Revenue Highest in Company History; Full Year Revenue Up 13% MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Dr. Bill Poland Will Present on the Strategic Use of Incorporating Adherence Data into Clinical Trial Predictions of Antiviral Therapies MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/...

Pharsight Strengthens Senior Management Team

John Murphy Appointed as New Senior Vice President of Consulting Services MOUNTAIN VIEW, Calif., April 29 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PALIPalisade Bio Inc
US$ 3.11
(122.14%)
23.13M
TRVITrevi Therapeutics Inc
US$ 3.55
(42.57%)
3.92M
SYTASiyata Mobile Inc
US$ 1.04
(39.04%)
17.48M
ZENAZenaTech Inc
US$ 7.1972
(26.49%)
6.36M
CDTConduit Pharmaceuticals Inc
US$ 0.1096
(24.12%)
38.47M
KROSKeros Therapeutics Inc
US$ 18.67
(-72.80%)
904.17k
SPGCSacks Parente Golf Inc
US$ 0.54
(-61.43%)
230.29k
AVGRAvinger Inc
US$ 0.441
(-46.22%)
111.05k
TFFPTFF Pharmaceuticals Inc
US$ 0.10
(-38.54%)
643.22k
HEPAHepion Pharmaceuticals Inc
US$ 0.36
(-38.46%)
19
CDTConduit Pharmaceuticals Inc
US$ 0.1096
(24.12%)
38.47M
PALIPalisade Bio Inc
US$ 3.11
(122.14%)
23.13M
SYTASiyata Mobile Inc
US$ 1.04
(39.04%)
17.48M
AMPGAmplitech Group Inc
US$ 2.27
(17.62%)
14.65M
LAESSEALSQ Corporation
US$ 1.2899
(12.17%)
10.48M

PHST Discussion

Ver más
No se encontraron comentarios